Brooks Leitner
@brooksleitner
@YaleMed MD/PhD Student | PhD in Cellular & Molecular Physiology @RachelPerryLab1 | former @NIH postbac & @UofMaryland Kinesiology
ID: 1130549823461969920
20-05-2019 19:04:17
227 Tweet
862 Followers
1,1K Following
Mental illness is a brain disorder? Right? We thought so. Hang on though, our new study JAMA Psychiatry shows that poor body health is a more pronounced manifestation of mental illness than poor brain health. jamanetwork.com/journals/jamap… 🧵1/9
Our lab’s first foray into sepsis metabolism is now published! 🧵 for more details. Congrats and thanks to Brooks Leitner and the rest of our team Yale Internal Medicine Yale MSTP
Intriguing study showing the cellular energetic consequences of dealing with chronic stress. All metabolic resources seem to go towards keeping up with ATP demand... What other cellular functions must be spared in order to keep up? Martin Picard
REVIEW Vincent Prevot, Sreekala Nampoothiri, Ruben Nogueiras et al. present glial cells as key mediators of energy balance through integrating peripheral signals in discrete #brain regions, highlighting their relevance in metabolic diseases. nature.com/articles/s4225…
By applying high-throughput biological omics techniques, researchers find that organ systems respond uniquely to support liver antioxidant synthesis to fight sepsis. Read more from #YaleEndocrinology team ⬇️ Brooks Leitner Rachel Perry medicine.yale.edu/intmed/news-ar…
Delighted to share our new manuscript led by Xinyi Zhang with valued collaborators including Won Dong Lee Brooks Leitner just out in AJP-Endocrinology and Metabolism Yale Cancer Center Yale Internal Medicine journals.physiology.org/doi/full/10.11…
Week 30 of the Human Psychobiology Project series presents a finding about the connection between the gut microbiome and depression. This finding was submitted by Brooks Leitner, and more information can found at pubmed.ncbi.nlm.nih.gov/35508109/.
Very excited to announce the acceptance of Ascent Bio (our Yale University AI-therapeutics spinout company) into the Merck Digital Sciences Studio accelerator and funding from Merck, Northpond Ventures (Northpond Ventures), and McKesson (McKesson Ventures)! mds.studio/news/meet-our-…